close icon

Bristol-Myers: Elliott Wave Setup can Double the Price

Bristol-Myers Squibb is in the process of acquiring Celgene in a $74 billion dollar cash-and-stock deal including debt. The deal faced opposition from hedge funds Wellington Management and Starboard Value, but ultimately gained shareholder approval on April 12th.

Arbitrageurs, who aim to profit from the discrepancy between the market price and the deal closing price, seem to have shorted BMY stock as a hedge, in order to protect their returns. The stock is set to open at $45.64 today, down from $54.38 in early March. In reality, BMY stock has been under pressure since July 2016, when it reached an all-time high of $77.12 a share.

The acquisition is expected to close in Q3 2019. From then on, management will have to deal with shareholder dilution, debt reduction and the integration of Celgene into Bristol-Myers. Despite the high quality of Celgene’s business, risks for long-term BMY investors have increased significantly. A lot can go wrong, but the actual outcome – positive or negative – will remain unknown for some time.

Bristol-Myers, A Pattern Has Emerged

Fortunately, we can look at the situation from another angle. It looks like all the news around BMY stock in the last three years, all the earnings reports, drug successes and failures, analysts’ upgrades and downgrades led to the formation of a recognizable Elliott Wave pattern. Take a look at it on the daily price chart of Bristol-Myers Squibb below.

Bristol-Myers setting the stage for a 100% rally

The daily chart reveals that the entire decline from $77.12 can be seen as an A-B-C flat correction. Waves A and B are simple a-b-c zigzags, while wave C appears to be an ending diagonal.

Prior to this retracement, BMY stock was in an uptrend. According to the Wave theory, once a correction is over the larger trend resumes. If we apply this here, it makes sense to expect a bullish reversal as wave 5 of C is poised to complete the entire pattern soon.

Despite all the risks, the market seems ready to give the BMY-Celgene deal its vote of confidence. The anticipated rally is supposed to regain all the value lost since July 2016. If this count is correct, a revisit of $77 a share is quite possible. Once there, $90 will not be too far away.

Did you like this analysis? Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

T Rowe Price Vulnerable After Fibonacci Encounter

Founded in 1937 and based in Baltimore, Maryland, T Rowe Price is one of the largest asset management companies in the world. At the end of Q1 2019 its assets under management stood at $1.11T. That is T for trillion. Besides, T Rowe Price is also a public company which is why it is of…

Read More »

Momo Inc. – The Tinder of China Looks Promising

Based in Beijing, China, Momo Inc. operates a mobile-based social and entertainment platform. The company was founded in 2011 and became public in late-2014. The Tinder of China, as Momo is often referred to, first turned a profit in 2015 and has been enjoying strong earnings and revenue growth in the last three years. Momo…

Read More »

TTD Stock: Don’t Let that 8-fold Surge Seduce You

The Trade Desk Inc. provides a self-service omni-channel software platform enabling clients to purchase and manage data-driven digital advertising campaigns. TTD stock is trading on NASDAQ since September 2016. In less than three years, the shares have surged from the IPO price of $28.75 to over $232 earlier this month. Early investors have managed to…

Read More »

Mondi Group: Little Known Firm, Well Known Pattern

Even Mondi Group themselves acknowledge that not too many people have heard their name. “Our name may not be familiar to the public, but our products are” is written on the second page of the company’s 2018 annual report. Mondi, listed on the London Stock Exchange, is a global paper and packaging company, headquartered in…

Read More »

Swedbank to Benefit from a Bullish Elliott Wave Cycle

It took Swedbank, one of Sweden’s biggest financial institutions, ten years to return to its pre-crisis glory. The stock rose from as low as SEK 14.70 in March 2009 to SEK 234 in February 2017 – less than SEK 2 below its February 2007 peak. And just when it looked like a new all-time high…

Read More »

FOSL Stock Ready to Exceed Expectations?

In October 2013, Fossil Group had a market cap of roughly $7.5 billion. The watchmaker was enjoying record sales and profits, which was supposed to propel FOSL stock, then hovering above $130 a share, even higher. Fast-forward six years and the company is currently valued at less than $650 million with the shares barely above…

Read More »

UnitedHealth Stock Looks Strong Despite Uncertainty

Whether Obamacare is unconstitutional or not is up to the policy makers, but the uncertainty surrounding the matter caused a broad selloff in the healthcare sector. Cigna, Humana, CVS Health and UnitedHealth lost a significant chunk of their respective market caps after the DOJ sided with a December 2018 Texas district court ruling that the…

Read More »

More analyses